pneumocystis

简明释义

英[njuːməʊˈsɪstɪs]美[nuˈmoʊˌsɪstɪs]

肺囊虫属

英英释义

单词用法

同义词

反义词

例句

1.Objective To improve the understanding of pneumocystis carinii pneumonia (PCP) and investigate the role of electron microscopical examination in the diagnosis of PCP.

目的提高对卡氏肺囊虫肺炎（PCP）的认识，探索电镜对卡氏肺囊虫肺炎的诊断意义以及预防PCP的方法。

2.The clinical feature is mainly prolonged fever and clinical manifestations included candidiasis, herpes simplex, pneumocystis pneumonia, pulmonary tuberculosis and so on.

临床特点以反复发热为主，主要临床表现为念珠菌病、单纯疱疹、肺孢子虫肺炎、肺结核等。

3.Pneumocystis carinii pneumonia, "PCP pneumonia, " now called Pneumocystis jiroveci pneumonia.

卡氏肺孢子虫肺炎（PCP 肺炎），现在称为耶氏肺孢子虫肺炎。

4.in infants infected with HIV, Pneumocystis jiroveci is one of the commonest causes of pneumonia, responsible for at least one quarter of all pneumonia deaths in HIV-infected infants.

在感染艾滋病毒的婴儿中，耶氏肺孢子菌是引起肺炎的最常见原因之一，占感染艾滋病毒的婴儿中所有肺炎死亡病例的至少四分之一。

5.Objective To study the ultra structure of Pneumocystis carinii on the process of development and reproduction, and the distribution in lung tissue.

目的研究卡氏肺孢子虫的超微结构、发育增殖过程及其在肺组织内的寄生情况，探讨其致病机制。

6.Methods: the rats were immunized by the major surface glycoprotein (MSG) of Pneumocystis carinii combined with IL - 12 as an adjuvant.

方法：用IL-12作为佐剂和卡氏肺孢子虫主要表面糖蛋白(MSG)一起免疫大鼠。

7.Patients with HIV are particularly vulnerable to pneumocystis carinii pneumonia.

HIV患者特别容易感染肺囊虫卡氏肺炎。

8.Treatment for pneumocystis pneumonia often includes antibiotics like trimethoprim-sulfamethoxazole.

治疗肺囊虫肺炎通常包括使用抗生素如甲氧苄啶-磺胺甲噁唑。

9.The doctor diagnosed the patient with pneumocystis pneumonia after reviewing the chest X-ray.

医生在查看胸部X光后诊断患者患有肺囊虫肺炎。

10.Individuals with weakened immune systems are at higher risk for pneumocystis infections.

免疫系统较弱的个体更容易感染肺囊虫。

11.Research is ongoing to better understand the lifecycle of pneumocystis organisms.

研究正在进行中，以更好地理解肺囊虫生物的生命周期。

作文

Pneumonia is a serious condition that can affect anyone, but it poses a particularly high risk to individuals with weakened immune systems. One of the lesser-known causes of pneumonia is pneumocystis, a type of fungus that can lead to a severe lung infection known as pneumocystis pneumonia (PCP). This condition primarily affects people with HIV/AIDS, cancer patients undergoing chemotherapy, and those who have received organ transplants. Understanding pneumocystis and its implications is crucial for both medical professionals and patients alike. The organism responsible for this infection, pneumocystis jirovecii, was once classified as a protozoan but is now recognized as a fungus. It is commonly found in the environment, and many healthy individuals carry it without ever developing symptoms. However, when the immune system is compromised, the organism can proliferate and cause significant respiratory illness. Symptoms of pneumocystis pneumonia may include a persistent dry cough, fever, shortness of breath, and fatigue. These symptoms can progress rapidly, making early diagnosis and treatment essential. Diagnosis of pneumocystis pneumonia typically involves a combination of clinical evaluation and laboratory tests. Physicians may perform chest X-rays or CT scans to assess the extent of lung involvement. Additionally, a sample of lung fluid may be obtained through bronchoscopy to confirm the presence of pneumocystis jirovecii. Once diagnosed, treatment usually involves the administration of antibiotics, such as trimethoprim-sulfamethoxazole, which are effective against this particular fungus. In severe cases, corticosteroids may also be prescribed to reduce inflammation in the lungs. Prevention of pneumocystis pneumonia is especially important for those at high risk. Individuals with HIV/AIDS should maintain their antiretroviral therapy to keep their immune system functioning optimally. For those who are at risk due to other medical conditions, prophylactic medications can be prescribed to prevent infection. Regular check-ups and monitoring can also help catch any signs of infection early, allowing for timely intervention. In conclusion, pneumocystis pneumonia is a significant health concern for immunocompromised individuals. Awareness of the risks associated with pneumocystis and understanding the symptoms can lead to quicker diagnoses and better outcomes. As research continues to evolve, it is vital for healthcare providers to stay informed about the latest treatments and prevention strategies to combat this potentially life-threatening infection. By fostering awareness and education about pneumocystis, we can work towards reducing its impact on vulnerable populations and improving overall public health.

肺炎是一种严重的疾病，可能影响任何人，但对免疫系统较弱的人群尤其危险。导致肺炎的一个鲜为人知的原因是肺囊虫，一种真菌，可导致一种称为肺囊虫肺炎（PCP）的严重肺部感染。这种病症主要影响HIV/AIDS患者、接受化疗的癌症患者以及接受器官移植的人。理解肺囊虫及其影响对于医疗专业人员和患者都至关重要。引起这种感染的生物体肺囊虫吉尔维西（pneumocystis jirovecii）曾被分类为原生动物，但现在被认为是一种真菌。它通常存在于环境中，许多健康个体携带它而不会出现任何症状。然而，当免疫系统受到损害时，该生物体可以繁殖并导致显著的呼吸道疾病。肺囊虫肺炎的症状可能包括持续的干咳、发热、呼吸急促和疲劳。这些症状可能迅速加重，因此早期诊断和治疗至关重要。肺囊虫肺炎的诊断通常涉及临床评估和实验室检测的结合。医生可能会进行胸部X光或CT扫描，以评估肺部受累的程度。此外，还可能通过支气管镜检查获取肺液样本，以确认是否存在肺囊虫吉尔维西。一旦确诊，治疗通常涉及使用抗生素，如复方磺胺甲噁唑，这对于这种特定真菌有效。在严重情况下，可能还会开处方类固醇以减少肺部的炎症。预防肺囊虫肺炎对高风险人群尤其重要。HIV/AIDS患者应维持抗逆转录病毒治疗，以保持免疫系统的最佳功能。对于因其他疾病而处于风险中的人，可以开处方预防性药物以防止感染。定期检查和监测也有助于尽早发现感染迹象，从而及时干预。总之，肺囊虫肺炎是免疫系统受损个体面临的重大健康问题。意识到与肺囊虫相关的风险并了解症状可以导致更快的诊断和更好的结果。随着研究的不断发展，医疗提供者必须保持对最新治疗和预防策略的了解，以应对这种潜在的威胁生命的感染。通过促进对肺囊虫的认识和教育，我们可以努力减少其对脆弱人群的影响，并改善整体公共健康。